◆ 会议时间:2023年3月10日至12日
◆ 会议地点:日本 福冈
◆ 会议简介:
2023年第87届日本循环器学会(JCS)年度科学会议将于2023年3月10日至12日在日本福冈举行。JCS年会是世界上最大的单一国家心脏病学会议之一,每年有超过15000人参加。
日本循环器学会(JCS)是日本及至世界上最负盛名的心血管疾病专业医学学会之一,现拥有超过26000名成员。JCS有着80多年的悠久历史,1935年日本临床心血管病学杂志创刊,1936年日本临床心血管病学会成立,1953年学会和期刊更名日本循环器学会(期刊)。JCS的业务范围广泛,包括发行期刊、制定指南和组织科学会议。JCS年度科学会议有约20,000名参与者。JCS还与AHA,ACC,ESC,韩国心脏病学会(KSC)和中国心脏病学会(CSC)等国外心脏病学会联合举办研讨会,并与亚洲国家相关组织宣合作开展临床试验和研究。未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)
第87回日本循環器学会学術集会(JCS2023)
The 87th Annual Scientific Meeting of the Japanese Circulation Society (JCS2023)
Dates/时间:
March 10 (Fri.) - 12 (Sun.), 2023
Venue/会场:
Fukuoka International Congress Center / Fukuoka Sunpalace / Marine Messe Fukuoka
Theme/主题:
New Challenge with Next Generation
重要日期:
|
Date of abstract registration starting |
Date of abstract registration ending |
Date of confirmation & modification of the abstracts ending |
Plenary Sessions / Symposia
|
July 7 (Thu.), 2022
10:00AM (JST) |
August 4 (Thu.),2022
06:00AM (JST) |
August 5 (Fri.),2022
06:00AM (JST) |
Regular Abstracts
常规摘要
|
September 28
(Wed.),2022
06:00AM (JST) |
September 30
(Fri.),2022
06:00AM (JST) |
Case Report Session
|
September 28
(Wed.),2022
06:00AM (JST) |
September 30
(Fri.),2022
06:00AM (JST) |
Late Breaking
(Clinical Trials / Cohort Studies)
|
August 1 (Mon.), 2022
10:00AM |
September 30
(Fri.),2022
06:00AM (JST) |
September 30
(Fri.),2022
06:00AM (JST) |
|
|
* |
In the detailed page, there is the link for abstract registration site. Please refer to the detailed page, and register your abstract before the deadline. |
|
Greetings from the Chairperson of JCS2023
I am pleased to announce that the 87th Annual Scientific Meeting of the Japanese Circulation Society (JCS2023) will take place from March 10th to 12th, 2023 in Fukuoka City.
COVID-19 is not yet completely under control and has had a great impact on JCS members’ clinical practice, research and education, as well as daily life. The Annual Scientific Meeting of the JCS has been held entirely or mainly online for the last three years, greatly limiting opportunities for members to exchange ideas and information. This could have long-term impacts particularly for early-career doctors and scientists who will lead the next generation of circulation research. To offer opportunities for face-to-face presentations and discussions, we are preparing to hold JCS2023 as an in-person event at Fukuoka International Congress Center, Fukuoka Sunpalace, Marine Messe Fukuoka and Fukuoka Kokusai Center, although parts of the event may be delivered online.
The theme of JCS2023 is “New Challenge with Next Generation.” The “next generation” implies a diverse group of early-career professionals, including doctors, scientists and medical staff who will lead cardiology in the future, as well as new technologies supporting cardiovascular practice and research. Personnel and technological developments are indispensable for making progress in the cardiovascular field, which should be driven by bold but flexible ideas. We strongly hope that through its multidisciplinary approach, JCS2023 will offer learning and networking opportunities as well as contribute to greater knowledge and skills.
The Mikamo Lecture and Mashimo Memorial Lecture will be delivered by Prof. Douglas L. Mann, Cardiovascular Division, Washington University School of Medicine, Missouri, USA and Prof. Yusuke Nakamura, Cancer Precision Medicine Center, respectively. We have also invited Prof. Robert Campbell, a Japanese literature academic at Waseda University, to deliver a special lecture.
We hope that all the members, especially early-career doctors, scientists and medical staff, will gather together in person in Fukuoka to discuss what can be done for the future, across generations and professions. We are working hard to meet you in person in March 2023, and sincerely look forward to welcoming you.
Hiroyuki Tsutsui, M.D., Ph.D.
Congress Chairperson of the 87th Annual Scientific Meeting of the Japanese Circulation Society
(Professor, Department of Cardiovascular Medicine, Kyushu University)
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|